XML 53 R38.htm IDEA: XBRL DOCUMENT
v3.25.3

Earnings Per Common Share (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Earnings Per Share [Abstract] |
Schedule of Computation of Basic and Diluted Earnings Per Share | The following table illustrates the computation of basic and diluted earnings per share (in thousands, except per share amounts):
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2025 |  | 2024 |  | 2025 |  | 2024
Numerator - Basic |  |  |  |  |  |  |
Net income (loss) | $ | (109,848) |  |  | $ | 92,738 |  |  | $ | (20,765) |  |  | $ | 256,631 |
Noncontrolling interests’ share in earnings | (7,274) |  |  | (6,866) |  |  | (21,856) |  |  | (18,036) |
Net income (loss) attributable to Healthpeak Properties, Inc. | (117,122) |  |  | 85,872 |  |  | (42,621) |  |  | 238,595 |
Less: Participating securities’ share in earnings | (134) |  |  | (197) |  |  | (714) |  |  | (610) |
Net income (loss) applicable to common shares | $ | (117,256) |  |  | $ | 85,675 |  |  | $ | (43,335) |  |  | $ | 237,985 |
Numerator - Dilutive |  |  |  |  |  |  |
Net income (loss) applicable to common shares | $ | (117,256) |  |  | $ | 85,675 |  |  | $ | (43,335) |  |  | $ | 237,985 |
Add: distributions on dilutive convertible units and other | — |  |  | 47 |  |  | — |  |  | 72 |
Dilutive net income (loss) available to common shares | $ | (117,256) |  |  | $ | 85,722 |  |  | $ | (43,335) |  |  | $ | 238,057 |
Denominator |  |  |  |  |  |  |
Basic weighted average shares outstanding | 694,930 |  |  | 699,349 |  |  | 696,380 |  |  | 667,536 |
Dilutive potential common shares - equity awards(1) | — |  |  | 137 |  |  | — |  |  | 150 |
Dilutive potential common shares - OP Units(2) | — |  |  | 660 |  |  | — |  |  | 410 |
Diluted weighted average common shares | 694,930 |  |  | 700,146 |  |  | 696,380 |  |  | 668,096 |
Earnings (loss) per common share |  |  |  |  |  |  |
Basic | $ | (0.17) |  |  | $ | 0.12 |  |  | $ | (0.06) |  |  | $ | 0.36 |
Diluted | $ | (0.17) |  |  | $ | 0.12 |  |  | $ | (0.06) |  |  | $ | 0.36 |
_______________________________________ (1)For each of the three and nine months ended September 30, 2025, the 1 million outstanding equity awards (restricted stock units and stock options) were anti-dilutive. For each of the three and nine months ended September 30, 2024, represents the dilutive impact of 1 million outstanding equity awards (restricted stock units and stock options). (2)For each of the three and nine months ended September 30, 2025, all 4 million outstanding OP Units were anti-dilutive. For each of the three and nine months ended September 30, 2024, represents the dilutive impact of 3 million outstanding OP Units.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration